Yu-Hung Wang
@wang_yu_hung
🩸Haematologist
🇹🇼 #Taiwan 🇬🇧 @CRUK_MI @OfficialUoM @EHA_Hematology SWG
#血液内科 #MDS #MPN #CMML
Opinions my own.
ID: 1313832788320301057
07-10-2020 13:25:31
3,3K Tweet
741 Followers
682 Following
Identifying disease-modifying potential in #myelofibrosis clinical trials doi.org/10.1182/blood.… #MPNsm MPN_Hub MPN Research Foundation Blood Journal
Trends in allogeneic transplantation for #favorable risk acute myeloid leukemia in first remission: a longitudinal study of >15 years from the ALWP of the EBMT nature.com/articles/s4140… #leusm #BMTsm The EBMT Mohamad Mohty The EBMT Trainee Committee Nicolaus Kröger
What an honor to write this commentary on Zaimoku et al. 👉10.1111/bjh.19712. together with Simona Pagliuca & Alberto Cardoso M. Lima, PhD British Journal of Haematology 👉onlinelibrary.wiley.com/doi/10.1111/bj…
Now online in Cancer Discovery: RNA shielding of p65 Is Required to Potentiate Oncogenic Inflammation in TET2-mutated #ClonalHematopoiesis - by Nana Adjoa Ben-Crentsil, Alexandre Gaspar Maia Mrinal Patnaik Eric Padron MD and colleagues doi.org/10.1158/2159-8… Mayo Clinic Moffitt Cancer Center
RNA shielding of P65 is required to potentiate oncogenic inflammation in TET2 mutated clonal hematopoiesis. pubmed.ncbi.nlm.nih.gov/39189614/ Our latest collaboration with Eric Padron MD Alexandre Gaspar Maia #TET2 #MALAT1 #CH Mayo Clinic Comprehensive Cancer Center Moffitt Cancer Center Cancer Discovery
REGISTER NOW FOR #ESHBMFS2024 ➡ bit.ly/3QL8Ja0 ESH-EBMT-EHA-IPIG 3rd Translational Research Conference: Bone Marrow Failure & Leukaemia Predisposition Syndromes 🗓️ Nov. 15-17, 2024 Chairs: Carmem Bonfim, Tim Brümmendorf, A. Risitano, Sharon A. Savage, M.D. #ESHCONFERENCES #bmfsm
Clinical relevance of NFYA splice variants in patients with acute myeloid leukaemia undergoing intensive chemotherapy doi.org/10.1111/bjh.19… #leusm #splicing British Journal of Haematology
📣 #ESHMICRO2025 CALL FOR ABSTRACTS ➡ bit.ly/3VcfYKN 5th Scientific Workshop Tumour Microenvironment & its Therapeutic Targeting 🗓️ Feb. 16-18, 2025 in London 🇬🇧 Chairs: D. Bonnet, Nitin Jain, Marina Konopleva, D. S. Krause, S. Mendez-Ferrer, K. Yong UCLH #ESHCONFERENCES
CONGRESS | #SOHO2024 Prithviraj Bose, MD Anderson Cancer Center, discusses key data on available JAK inhibitors to help optimize their selection for treatment of #myelofibrosis. Generally, ruxolitinib and fedratinib are better suited for the myeloproliferative phenotype, while momelotinib
🚀 Excited to share our latest paper in eLife - the journal! 📊 We introduce #ImmCellTyper, a novel toolkit for analysing CyTOF data with high accuracy. Check it out! Many thanks CRUKCOLcentre, for the support. #Immunology #CyTOF #AI #KCL King's College London doi.org/10.7554/eLife.… eLife - the journal
@MPN SM MPN Voice GUY'S MYELOID CENTRE MPNAdvocatesNetwork Thinking of all colleagues, researchers, patients, their families carers and all in the MPN family on MPN Awareness Day 2024. Let’s keep working together and striving for the best!
HOPE toward a CURE for MPNs! Mark #MPN awareness day 24 w/gratitude for amazing community of #MPN patients/caregivers & researchers & hope for #MPNCure! MPN Research Foundation Global MPN Scientific Foundation MPNAdvocatesNetwork MPN Ad&Ed Int'l Naveen Pemmaraju, MD J.J. Kiladjian Levine Cancer
Thanks to our THEMA member Raphael Itzykson for sharing his impressive work on targeting cystine import in AML #FirstTHEMALeukemiaSymposium
As session chairs, you also had the chance to meet our THEMA members : J.J. Kiladjian #FrancoisePflumio #AndréBaruchel #VahidAsnafi #ThorstenBraun #HélèneCavé
After the scientific symposium, we held yesterday working groups with THEMA leaders to discuss how to shape this new THEMA Saint-Louis Institute. Exciting times ahead J.J. Kiladjian Puissant Lab Jean Soulier Emmanuel RAFFOUX Dombret Hervé David Michonneau Diana Passaro Benajiba Lina